These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26149967)

  • 1. Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complex.
    Mohammad N; Singh SV; Malvi P; Chaube B; Athavale D; Vanuopadath M; Nair SS; Nair B; Bhat MK
    Sci Rep; 2015 Jul; 5():11853. PubMed ID: 26149967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas/FasL-dependent and -independent activation of caspase-8 in doxorubicin-treated human breast cancer MCF-7 cells: ADAM10 down-regulation activates Fas/FasL signaling pathway.
    Liu WH; Chang LS
    Int J Biochem Cell Biol; 2011 Dec; 43(12):1708-19. PubMed ID: 21854868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
    Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
    Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
    Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
    J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver.
    Patel N; Joseph C; Corcoran GB; Ray SD
    Toxicol Appl Pharmacol; 2010 Jun; 245(2):143-52. PubMed ID: 20144634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice.
    Liu X; Chua CC; Gao J; Chen Z; Landy CL; Hamdy R; Chua BH
    Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H933-9. PubMed ID: 14766674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
    Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
    Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple actions of pifithrin-alpha on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells.
    Chua CC; Liu X; Gao J; Hamdy RC; Chua BH
    Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2606-13. PubMed ID: 16687611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Fas expression by RNAi modulates 5-fluorouracil-induced apoptosis in HCT116 cells expressing wild-type p53.
    Borralho PM; Moreira da Silva IB; Aranha MM; Albuquerque C; Nobre Leitão C; Steer CJ; Rodrigues CM
    Biochim Biophys Acta; 2007 Jan; 1772(1):40-7. PubMed ID: 17056233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis.
    Xu Y; Diao Y; Qi S; Pan X; Wang Q; Xin Y; Cao X; Ruan J; Zhao Z; Luo L; Liu C; Yin Z
    Cell Signal; 2013 May; 25(5):1176-85. PubMed ID: 23357534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azacytidine-induced Chemosensitivity to Doxorubicin in Human Breast Cancer MCF7 Cells.
    Khan GN; Kim EJ; Shin TS; Lee SH
    Anticancer Res; 2017 May; 37(5):2355-2364. PubMed ID: 28476801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comb-like amphiphilic polypeptide-based copolymer nanomicelles for co-delivery of doxorubicin and P-gp siRNA into MCF-7 cells.
    Suo A; Qian J; Zhang Y; Liu R; Xu W; Wang H
    Mater Sci Eng C Mater Biol Appl; 2016 May; 62():564-73. PubMed ID: 26952460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
    Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
    Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin exerts cytotoxic effects through cell cycle arrest and Fas-mediated cell death.
    Kim HS; Lee YS; Kim DK
    Pharmacology; 2009; 84(5):300-9. PubMed ID: 19829019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance.
    Wang H; Yin H; Yan F; Sun M; Du L; Peng W; Li Q; Feng Y; Zhou Y
    Oncotarget; 2015 Feb; 6(5):2827-42. PubMed ID: 25605018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cationic prodrug/therapeutic gene nanocomplex for the synergistic treatment of tumors.
    Lu X; Wang QQ; Xu FJ; Tang GP; Yang WT
    Biomaterials; 2011 Jul; 32(21):4849-56. PubMed ID: 21458064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling.
    Wennerberg E; Sarhan D; Carlsten M; Kaminskyy VO; D'Arcy P; Zhivotovsky B; Childs R; Lundqvist A
    Int J Cancer; 2013 Oct; 133(7):1643-52. PubMed ID: 23504627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose doxorubicin loaded extracellular vesicles combined Fas/FasL pathway-mediated chemo-sensitization and immunotherapy against tumor.
    Wang F; Qin S; Zhang J; Huang M; Liu Q; Xu P; Hu Y
    Int J Pharm; 2024 Jul; 660():124349. PubMed ID: 38885778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiopoietin-1 inhibits doxorubicin-induced human umbilical vein endothelial cell death by modulating fas expression and via the PI3K/Akt pathway.
    Yin D; Li C; Kao RL; Ha T; Krishnaswamy G; Fitzgerald M; Stuart CA
    Endothelium; 2004; 11(5-6):247-52. PubMed ID: 15763944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.